# ALX4

## Overview
The ALX4 gene encodes the ALX homeobox 4 protein, a transcription factor that plays a pivotal role in the development of craniofacial structures and epidermal tissues. This protein is characterized by a paired-type homeodomain, which facilitates its binding to DNA and regulation of gene expression. ALX4 is primarily expressed in mesenchymal condensations, where it influences mesenchymal-epithelial interactions crucial for embryogenesis (Kayserili2009ALX4; Hudson1998Alx4). The protein's function is essential for the proper development of bones, hair follicles, and teeth, as it regulates key signaling pathways such as Wnt/beta-catenin (Kayserili2009ALX4). Mutations in the ALX4 gene can lead to a range of developmental disorders, including craniofacial and skeletal abnormalities, highlighting its clinical significance (Altunoglu2014Mild; Mavrogiannis2001Haploinsufficiency).

## Structure
The ALX4 protein is a transcription factor characterized by a paired-type homeodomain, which is a DNA-binding domain crucial for its function in craniofacial development. This homeodomain is highly conserved and shares significant identity with related proteins such as Alx-3 and Cart-1, as well as the Drosophila protein aristaless, indicating a common structural motif (Qu1997Alx4:). The homeodomain typically forms a helix-turn-helix structure, which is essential for its DNA-binding capability (Qu1997Alx4:).

The ALX4 protein also contains a conserved motif at the carboxyl terminus known as the paired-tail, suggesting a conserved biochemical function (Qu1997Alx4:). The protein is predicted to have two potential initiation sites, resulting in proteins of different lengths, which may influence its functional diversity (Hudson1998Alx4). The presence of a proline-rich region downstream of the homeodomain is important for its transcriptional activation ability (Hudson1998Alx4).

While specific details on the secondary, tertiary, or quaternary structures, as well as post-translational modifications or splice variant isoforms, are not provided in the available context, the protein's ability to form homodimers or heterodimers with other paired-type homeodomains is noted, which may relate to its quaternary structure (Qu1997Alx4:).

## Function
The ALX4 gene encodes a transcription factor that plays a critical role in craniofacial and epidermal development. In healthy human cells, ALX4 is involved in the differentiation and patterning processes necessary for proper craniofacial and epidermal development. It is primarily expressed in mesenchymal condensations, which are crucial for mesenchymal-epithelial interactions during embryogenesis (Kayserili2009ALX4; Hudson1998Alx4). ALX4 is active in the nucleus, where it binds to DNA through a homeodomain, influencing the transcription of target genes that regulate cell differentiation and tissue development (Kayserili2009ALX4; Hudson1998Alx4).

The gene is essential for the development of various tissues, including bones, hair follicles, and teeth, by regulating signaling pathways such as Wnt/beta-catenin, which are important for hair follicle regulation and epidermal architecture (Kayserili2009ALX4). ALX4's expression is associated with tissues that depend on epithelial-mesenchymal interactions, and it may play a role in the development of organs like hair, teeth, and mammary glands (Hudson1998Alx4). The proper localization of ALX4 to the nucleus is crucial for its function, as mutations can lead to mislocalization and loss of function, resulting in developmental abnormalities (Kayserili2009ALX4).

## Clinical Significance
Mutations in the ALX4 gene are associated with a variety of craniofacial and skeletal abnormalities. Heterozygous loss-of-function mutations in ALX4 are linked to enlarged parietal foramina, characterized by openings in the parietal bones of the skull (Altunoglu2014Mild; Mavrogiannis2001Haploinsufficiency). Biallelic (homozygous) mutations can result in more severe phenotypes, including alopecia, cranium bifidum, hypertelorism, microphthalmia, and alar clefting, which are part of frontonasal dysplasias (FNDs) (Kariminejad2014Skull; Altunoglu2014Mild).

ALX4 mutations can also lead to genitourinary anomalies, such as cryptorchidism and epispadias, and are implicated in Bladder-Exstrophy-Epispadias-Complex (BEEC) (Chen2020Variants). In livestock, a specific mutation in ALX4 is linked to tibial hemimelia syndrome in Galloway cattle, characterized by skeletal malformations (Brenig2015A).

The phenotypic expression of ALX4 mutations can vary significantly, influenced by genetic and non-genetic factors, leading to a broad spectrum of clinical presentations (Altunoglu2014Mild). This variability necessitates careful genetic counseling, as the outcomes can be unpredictable, especially in offspring of heterozygotes (Altunoglu2014Mild).

## Interactions
ALX4 interacts with DNA and other proteins to regulate gene expression. It binds to specific DNA elements, particularly P3 elements, as a cooperative dimer, showing high affinity and specificity for palindromic repeats of the sequence 5'-TAAT-3' (Tucker1999Sitespecific). The binding preference is influenced by the presence of a glutamine at position 50 in the homeodomain, which dictates the preference for P3 elements (Tucker1999Sitespecific). ALX4 can form homodimers and heterodimers with other paired class homeodomain proteins, such as Goosecoid (Gsc). These dimers exhibit unique DNA binding properties, allowing for distinct transcriptional responses (Tucker1999Sitespecific).

ALX4 also interacts with the transcriptional repressor Gsc, forming heterodimers that preferentially bind to the P3C element. This interaction is dependent on the presence of a DNA binding site and can antagonize ALX4-mediated activation, particularly on P3C sites, through Gsc's engrailed homology one (eh-1) domain (Tucker1999Sitespecific). The ALX4 protein's ability to form dimers and interact with DNA is mediated through its N-terminal ARM domain, which is crucial for cooperative DNA binding and transcriptional activation (Cain2024Structural). These interactions are significant in developmental processes, such as craniofacial development and limb formation (Cain2024Structural).


## References


[1. (Mavrogiannis2001Haploinsufficiency) Lampros A. Mavrogiannis, Ileana Antonopoulou, Alica Baxová, Stepán Kutílek, Chong A. Kim, Sofia M. Sugayama, Alberto Salamanca, Steven A. Wall, Gillian M. Morriss-Kay, and Andrew O.M. Wilkie. Haploinsufficiency of the human homeobox gene alx4 causes skull ossification defects. Nature Genetics, 27(1):17–18, January 2001. URL: http://dx.doi.org/10.1038/83703, doi:10.1038/83703. This article has 125 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/83703)

[2. (Kariminejad2014Skull) Ariana Kariminejad, Bita Bozorgmehr, Houman Alizadeh, Siavash Ghaderi‐Sohi, Güven Toksoy, Zehra Oya Uyguner, and Hülya Kayserili. Skull defects, alopecia, hypertelorism, and notched alae nasi caused by homozygous alx4 gene mutation. American Journal of Medical Genetics Part A, 164(5):1322–1327, March 2014. URL: http://dx.doi.org/10.1002/ajmg.a.36008, doi:10.1002/ajmg.a.36008. This article has 15 citations.](https://doi.org/10.1002/ajmg.a.36008)

[3. (Altunoglu2014Mild) Umut Altunoglu, Bilge Satkın, Zehra Oya Uyguner, and Hülya Kayserili. Mild nasal clefting may be predictive for alx4 heterozygotes. American Journal of Medical Genetics Part A, 164(8):2054–2058, April 2014. URL: http://dx.doi.org/10.1002/ajmg.a.36578, doi:10.1002/ajmg.a.36578. This article has 12 citations.](https://doi.org/10.1002/ajmg.a.36578)

[4. (Kayserili2009ALX4) Hulya Kayserili, Elif Uz, Carien Niessen, Ibrahim Vargel, Yasemin Alanay, Gokhan Tuncbilek, Gokhan Yigit, Oya Uyguner, Sukru Candan, Hamza Okur, Serkan Kaygin, Sevim Balci, Emin Mavili, Mehmet Alikasifoglu, Ingo Haase, Bernd Wollnik, and Nurten Ayse Akarsu. Alx4 dysfunction disrupts craniofacial and epidermal development. Human Molecular Genetics, 18(22):4357–4366, August 2009. URL: http://dx.doi.org/10.1093/hmg/ddp391, doi:10.1093/hmg/ddp391. This article has 103 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddp391)

[5. (Qu1997Alx4:) Shimian Qu, Liyeng Li, and Ron Wisdom. Alx-4: cdna cloning and characterization of a novel paired-type homeodomain protein. Gene, 203(2):217–223, December 1997. URL: http://dx.doi.org/10.1016/s0378-1119(97)00497-6, doi:10.1016/s0378-1119(97)00497-6. This article has 36 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/s0378-1119(97)00497-6)

[6. (Tucker1999Sitespecific) S. Craig Tucker and Ron Wisdom. Site-specific heterodimerization by paired class homeodomain proteins mediates selective transcriptional responses. Journal of Biological Chemistry, 274(45):32325–32332, November 1999. URL: http://dx.doi.org/10.1074/jbc.274.45.32325, doi:10.1074/jbc.274.45.32325. This article has 45 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.274.45.32325)

[7. (Brenig2015A) Bertram Brenig, Ekkehard Schütz, Michael Hardt, Petra Scheuermann, and Markus Freick. A 20 bp duplication in exon 2 of the aristaless-like homeobox 4 gene (alx4) is the candidate causative mutation for tibial hemimelia syndrome in galloway cattle. PLOS ONE, 10(6):e0129208, June 2015. URL: http://dx.doi.org/10.1371/journal.pone.0129208, doi:10.1371/journal.pone.0129208. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0129208)

8. (Cain2024Structural) Structural and biochemical characterization of the ALX4 dimer reveals novel insights into how disease alleles impact ALX4 function. This article has 0 citations.

[9. (Chen2020Variants) Ching H. Chen, Juan C. Bournat, Nathan Wilken, Jill A. Rosenfeld, Jason Zhang, Abhishek Seth, and Carolina J. Jorgez. Variants in alx4 and their association with genitourinary defects. Andrology, 8(5):1243–1255, July 2020. URL: http://dx.doi.org/10.1111/andr.12815, doi:10.1111/andr.12815. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/andr.12815)

[10. (Hudson1998Alx4) Rhea Hudson, Aiko Taniguchi-Sidle, Kata Boras, O’Neil Wiggan, and Paul A. Hamel. Alx-4, a transcriptional activator whose expression is restricted to sites of epithelial-mesenchymal interactions. Developmental Dynamics, 213(2):159–169, October 1998. URL: http://dx.doi.org/10.1002/(SICI)1097-0177(199810)213:2<159::AID-AJA1>3.0.CO;2-F, doi:10.1002/(sici)1097-0177(199810)213:2<159::aid-aja1>3.0.co;2-f. This article has 69 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/(SICI)1097-0177(199810)213:2)